Healthcare Triangle, Inc. (HCTI) entered into a definitive agreement on January 22 2026 to acquire the shares of Spain‑based Teyame 360 SL and Datono Mediacion SL for a total consideration of up to $50 million. The deal, effective January 1 2026, will close on January 29 2026 subject to customary conditions and shareholder approval. The purchase price is structured as a mix of cash, common stock, non‑voting convertible preferred stock, and contingent earn‑out equity.
The acquisition is designed to embed Teyame’s AI‑powered omnichannel customer‑experience platform into HCTI’s existing CloudEz, DataEz, and Readabl.AI suite, creating a unified, intelligent ecosystem for patients, providers, and payers. By adding the platform’s multilingual chatbot, real‑time analytics, and automation capabilities, HCTI will extend its SaaS footprint into Europe and Latin America, positioning the company as a comprehensive digital innovator rather than a traditional healthcare IT vendor.
Financially, the transaction is projected to generate approximately $32 million in incremental annual revenue and $3.6 million in incremental EBITDA for fiscal year 2025, and $38 million in next‑twelve‑month revenue with $5 million in EBITDA. These figures represent a more than 200 % increase over HCTI’s last‑12‑month revenue of $12.9 million and a dramatic turnaround from the $5.9 million negative EBITDA reported for the same period. The deal therefore offers a substantial upside to the company’s top‑line growth and profitability trajectory.
Management highlighted the strategic fit in a joint statement. COO Sujatha Ramesh said, “Integrating Teyame’s AI‑powered engagement platform with our healthcare technologies positions us to deliver a next‑generation, intelligent ecosystem for patients, providers, and expanding our SaaS footprint into Europe and Latin America.” CFO David Ayanoglou added, “The transaction will bring real‑world lived experience of Agentic Gen AI and is about to change the game for HCTI.”
Following the announcement, HCTI’s shares surged 84.47 % in pre‑market trading, reflecting investor enthusiasm for the deal’s projected revenue lift, EBITDA improvement, and the company’s shift toward AI‑driven solutions. The market reaction was driven by the clear upside to HCTI’s financials and the strategic expansion into high‑growth geographies.
The acquisition follows a prior Letter of Intent issued on October 9 2025 and an Advance Agreement on December 10 2025, underscoring HCTI’s long‑term commitment to this transformation. The company has also secured up to $15 million in convertible promissory notes, with a $7.5 million tranche closing at a 20 % discount, providing additional liquidity to support the integration and future growth initiatives.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.